Intangible assets: valuation and economic benefit -Pfizer case study-

dc.date.accessioned	2023-09-11T06:58:38Z
dc.date.available	2023-09-11T06:58:38Z
dc.date.issued	2022-12-02
dc.description.abstract	In this paper, we have explained the economic importance of intangible assets to make the right decision on how to use them in an optimal way. At first, we tried to define the intangible assets, through an economic analysis of the characteristics of these assets, in addition to that we explained he most important way to evaluate them. Then in the next step, and by applying to Pfizer, we calculated some indicators before and after deleting the intangible assets, to notice their impact in creating value on the company. The most important result that was reached is that intangible assets have a direct role in creating value in Pfizer, and by removing them from the financial statements, the company’s performance will decline and cannot be dispensed with in the evaluation of the company.	ar
dc.identifier.issn	2352-9962
dc.identifier.issn	E-ISSN 2572-0147
dc.identifier.uri	http://hdl.handle.net/123456789/15481
dc.language.iso	en	ar
dc.publisher	University of Larbi Ben M'hidi Oum EL Bouaghi	ar
dc.subject	Intangible Assets	ar
dc.subject	Value Creation	ar
dc.subject	Pfizer	ar
dc.title	Intangible assets: valuation and economic benefit -Pfizer case study-	ar
dc.title.alternative	الأصول غير الملموسة: التقييم والمنفعة الإقتصادية - شركة فايزرنموذجا	ar
dc.type	Article	ar

Now showing 1 - 1 of 1

Name:: Intangible Assets -valuation and Economic Benefit- -Pfizer Case Study-.pdf
Size:: 925.37 KB
Format:: Adobe Portable Document Format
Description:

Now showing 1 - 1 of 1